PSYENCE BIOMEDICAL LTD. (PBM) Corporate Subsidiaries
PSYENCE BIOMEDICAL LTD. (PBM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PBM
CIK: 1985062
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 03/31
State: A6
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MNP LLP
Auditor SinceSince 3/31/2023 12:00:00 AM
Lead Engagement PartnerEduard Shvekher
Audit LocationToronto, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-15 | — | SCHEDULE 13D/A Filing | 0001213900-26-109613 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-05 | — | SCHEDULE 13G Filing | 0000929638-26-003844 | View SEC Doc Filr Page |
| 6-K | 2026-10-05 | 2026-10-05 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-106630 | View SEC Doc Filr Page |
| 6-K | 2026-09-28 | 2026-09-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-103733 | View SEC Doc Filr Page |
| 6-K | 2026-09-23 | 2026-09-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-102358 | View SEC Doc Filr Page |
| 6-K | 2026-09-14 | 2026-09-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-099451 | View SEC Doc Filr Page |
| EFFECT | 2026-09-01 | — | EFFECT Filing | 9999999995-26-002862 | View SEC Doc Filr Page |
| S-8 | 2026-08-26 | — | REGISTRATION STATEMENT | 0001213900-26-093629 | View SEC Doc Filr Page |
| F-3 | 2026-08-26 | — | REGISTRATION STATEMENT | 0001213900-26-093628 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-086123 | View SEC Doc Filr Page |
| 20-F | 2026-06-22 | 2026-03-31 | ANNUAL REPORT | 0001213900-26-070607 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-10 | — | SCHEDULE 13G/A Filing | 0001376474-26-000435 | View SEC Doc Filr Page |
| 6-K | 2026-06-05 | 2026-06-05 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-065824 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-03 | — | SCHEDULE 13D Filing | 0001213900-26-064484 | View SEC Doc Filr Page |
| 6-K | 2026-04-23 | 2026-04-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-047089 | View SEC Doc Filr Page |
| 6-K | 2026-04-20 | 2026-04-20 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-045373 | View SEC Doc Filr Page |
| 6-K | 2026-04-17 | 2026-04-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-045238 | View SEC Doc Filr Page |
| 6-K | 2026-04-15 | 2026-04-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-043636 | View SEC Doc Filr Page |
| 6-K | 2026-03-02 | 2026-03-02 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-021987 | View SEC Doc Filr Page |
| 6-K | 2026-02-20 | 2026-02-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-018919 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-19 | — | SCHEDULE 13G Filing | 0001376474-26-000189 | View SEC Doc Filr Page |
| 6-K | 2026-02-19 | 2026-02-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-018155 | View SEC Doc Filr Page |
| 6-K | 2026-02-13 | 2026-02-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-016391 | View SEC Doc Filr Page |
| 6-K | 2026-02-12 | 2026-02-12 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-015229 | View SEC Doc Filr Page |
| 6-K | 2026-01-29 | 2026-01-29 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-009093 | View SEC Doc Filr Page |